| Name | Title | Contact Details |
|---|
Bringing over 75 years of combined industry experience, Incline P&C Group is the premier insurance program market services firm. Privately owned and operated with an exclusive focus on the program insurance market, the executive teams experience and expertise combined with effective underwriting discipline and risk management provides each client with various platforms and associated services to meet almost any need in the industry.
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.
"Love of invention will never end." - Carl Benz Learn more about us as we continue to pioneer the future of driving excellence. Data privacy: mb4.me/provider_privacy Imprint: Mercedes-Benz AG Mercedesstraße 120 D-70372 Stuttgart Deutschland Tel.: +49 7 11 17-0 E-Mail: dialog.mb@mercedes-benz.com Vertreten durch den Vorstand: Ola Källenius (Vorsitzender), Jörg Burzer, Renata Jungo Brüngger, Sabine Kohleisen, Harald Wilhelm, Markus Schäfer, Britta Seeger Vorsitzender des Aufsichtsrats: Martin Brudermüller Handelsregister beim Amtsgericht Stuttgart, Nr. HRB 762873 Umsatzsteueridentifikationsnummer: DE321281763
At POCN, we seek to support the careers and clinical practices of NPs and PAs - Advanced Clinicians by partnering with life science companies who recognize their critical role on the front lines of healthcare. We are the largest network of Advanced Clinicians in the U.S. and strive to support and enable success for them at every turn. POCN provides Advanced Clinicians with an opportunity engine to grow their careers, earn valuable financial incentives, and increase their clinical knowledge and practice productivity. Recognizing the vital relationship between NPs, PAs, and the broader healthcare and life sciences industries, POCN specializes in developing peer–validated programs that include engaging live and virtual events, helpful patient education resources, incentivized market research programs, clinical reference and prescribing tools, promoted speaking opportunities, as well as CME and continuous learning modules on a variety of disease states and therapies.
ECIJA, with more than 25 years of experience, is in the Top 10 of the best firms in Spain, according to the prestigious rankings of Chambers & Partners and The Legal 500 and has established itself in the first place as a full service law firm. It has been recognised by The Lawyer as the best TMT firm in Europe and by the Financial Times as the most innovative firm on continental Europe. Its relevance in the Spanish market has been recognised by Expansión and Forbes, which have recognised it as the best firm in Digital Economy in Spain. ECIJA has a team of more than 200 partners and 1000 professionals globally, distributed in countries such as Spain, Portugal, Colombia, Chile, Honduras, Costa Rica, Dominican Republic, Nicaragua, Guatemala, El Salvador, Puerto Rico, Panama, Mexico, Brazil, Ecuador, Argentina and Uruguay. ECIJA is a full-service firm, with core practices in Corporate, M&A, Commercial and TMT, and large labor, litigation and tax groups. The Firm has offices in Spain, Portugal, USA, Central & Latin America and collaborates in all EU and worldwide jurisdictions. The Firm started in the year 1997 and has grown since then to become a full service Firm with presence in all areas of law and sectors. Our Legal Services include: Private Corporate Law, including: -Mergers and Acquisitions (M&A) -Private Equity and Venture Capital -General Corporate Law -Banking Law -Capital Markets -Competition Law and European Law -Human Resources & Employment Benefits -IT, Media, Data Protection and IP Law -Litigation and Arbitration -Project Finance -Public Law -Real Estate and Planning Law -Risk & Compliance -Tax To discuss how ECIJA attorneys can assist you and your business, please visit our website (www.ecija.com)